NEW YORK – Bio-Techne announced Wednesday that it has expanded its long-term partnership between its spatial biology subsidiary Advanced Cell Diagnostics (ACD) and Danaher subsidiary Leica Biosystems.
Under the expanded spatial multiomic collaboration, the companies have automated ACD's RNAscope Multiomic LS Assay and protease-free workflows on Leica's Bond RX research staining instrument. The assay allows for simultaneous fluorescent detection of up to six RNA and/or protein biomarkers on the same slide, Bio-Techne said in a statement.
ACD also introduced a protease-free workflow for RNAscope 2.5 single-plex assays on the Bond RX staining instrument, the company said.
"The automation of Bio-Techne's innovative RNAscope protease-free assays on the Leica Bond RX platform marks a significant milestone in spatial multiomics research," Matt McManus, president of Bio-Techne's Diagnostics and Spatial Biology segment, said in a statement. "High-precision visualization of RNA and protein biomarkers on the same slide empowers researchers with a streamlined, fully automated solution that preserves sample integrity and accelerates scientific discoveries in translational and clinical research."
Bio-Techne and Leica first partnered in 2015 to deliver automated in situ hybridization workflows to streamline spatial biology research.